The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.
The global Hospital-Acquired Disease Testing market size is expected to reach US$ 706.1 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Hospital-Acquired Disease Testing in various end use industries.
The expanding demands from the Small and Medium Sized Hospitals and Large Sized Hospitals, are propelling Hospital-Acquired Disease Testing market. UTI Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the SSI Testing segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hospital-Acquired Disease Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hospital-Acquired Disease Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hospital-Acquired Disease Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hospital-Acquired Disease Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hospital-Acquired Disease Testing covered in this report include Diatherix Laboratories, Gen-Probe, Qiagen, F. Hoffmann-La Roche, Cepheid, Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation and Nordion, etc.
The global Hospital-Acquired Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Diatherix Laboratories
- Gen-Probe
- Qiagen
- F. Hoffmann-La Roche
- Cepheid
- Life Technologies Corporation
- Meridian Biosciences
- Cantel Medical Corporation
- Nordion
Global Hospital-Acquired Disease Testing market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hospital-Acquired Disease Testing market, Segment by Type:
- UTI Testing
- SSI Testing
- Pneumococcal Infections Testing
- Bloodstream Infections Testing
- MRSA Testing
Global Hospital-Acquired Disease Testing market, by Application
- Small and Medium Sized Hospitals
- Large Sized Hospitals
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hospital-Acquired Disease Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Hospital-Acquired Disease Testing
1.1 Hospital-Acquired Disease Testing Market Overview
1.1.1 Hospital-Acquired Disease Testing Product Scope
1.1.2 Hospital-Acquired Disease Testing Market Status and Outlook
1.2 Global Hospital-Acquired Disease Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Hospital-Acquired Disease Testing Market Size by Region (2018-2029)
1.4 Global Hospital-Acquired Disease Testing Historic Market Size by Region (2018-2023)
1.5 Global Hospital-Acquired Disease Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Hospital-Acquired Disease Testing Market Size (2018-2029)
1.6.1 North America Hospital-Acquired Disease Testing Market Size (2018-2029)
1.6.2 Europe Hospital-Acquired Disease Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Hospital-Acquired Disease Testing Market Size (2018-2029)
1.6.4 Latin America Hospital-Acquired Disease Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Hospital-Acquired Disease Testing Market Size (2018-2029)
2 Hospital-Acquired Disease Testing Market by Type
2.1 Introduction
2.1.1 UTI Testing
2.1.2 SSI Testing
2.1.3 Pneumococcal Infections Testing
2.1.4 Bloodstream Infections Testing
2.1.5 MRSA Testing
2.2 Global Hospital-Acquired Disease Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Hospital-Acquired Disease Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Hospital-Acquired Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Hospital-Acquired Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Hospital-Acquired Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Hospital-Acquired Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Hospital-Acquired Disease Testing Revenue Breakdown by Type (2018-2029)
3 Hospital-Acquired Disease Testing Market Overview by Application
3.1 Introduction
3.1.1 Small and Medium Sized Hospitals
3.1.2 Large Sized Hospitals
3.2 Global Hospital-Acquired Disease Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Hospital-Acquired Disease Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Hospital-Acquired Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Hospital-Acquired Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Hospital-Acquired Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Hospital-Acquired Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Hospital-Acquired Disease Testing Revenue Breakdown by Application (2018-2029)
4 Hospital-Acquired Disease Testing Competition Analysis by Players
4.1 Global Hospital-Acquired Disease Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hospital-Acquired Disease Testing as of 2022)
4.3 Date of Key Players Enter into Hospital-Acquired Disease Testing Market
4.4 Global Top Players Hospital-Acquired Disease Testing Headquarters and Area Served
4.5 Key Players Hospital-Acquired Disease Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Hospital-Acquired Disease Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Diatherix Laboratories
5.1.1 Diatherix Laboratories Profile
5.1.2 Diatherix Laboratories Main Business
5.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Products, Services and Solutions
5.1.4 Diatherix Laboratories Hospital-Acquired Disease Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Diatherix Laboratories Recent Developments
5.2 Gen-Probe
5.2.1 Gen-Probe Profile
5.2.2 Gen-Probe Main Business
5.2.3 Gen-Probe Hospital-Acquired Disease Testing Products, Services and Solutions
5.2.4 Gen-Probe Hospital-Acquired Disease Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Gen-Probe Recent Developments
5.3 Qiagen
5.3.1 Qiagen Profile
5.3.2 Qiagen Main Business
5.3.3 Qiagen Hospital-Acquired Disease Testing Products, Services and Solutions
5.3.4 Qiagen Hospital-Acquired Disease Testing Revenue (US$ Million) & (2018-2023)
5.3.5 F. Hoffmann-La Roche Recent Developments
5.4 F. Hoffmann-La Roche
5.4.1 F. Hoffmann-La Roche Profile
5.4.2 F. Hoffmann-La Roche Main Business
5.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Products, Services and Solutions
5.4.4 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue (US$ Million) & (2018-2023)
5.4.5 F. Hoffmann-La Roche Recent Developments
5.5 Cepheid
5.5.1 Cepheid Profile
5.5.2 Cepheid Main Business
5.5.3 Cepheid Hospital-Acquired Disease Testing Products, Services and Solutions
5.5.4 Cepheid Hospital-Acquired Disease Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Cepheid Recent Developments
5.6 Life Technologies Corporation
5.6.1 Life Technologies Corporation Profile
5.6.2 Life Technologies Corporation Main Business
5.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Products, Services and Solutions
5.6.4 Life Technologies Corporation Hospital-Acquired Disease Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Life Technologies Corporation Recent Developments
5.7 Meridian Biosciences
5.7.1 Meridian Biosciences Profile
5.7.2 Meridian Biosciences Main Business
5.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Products, Services and Solutions
5.7.4 Meridian Biosciences Hospital-Acquired Disease Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Meridian Biosciences Recent Developments
5.8 Cantel Medical Corporation
5.8.1 Cantel Medical Corporation Profile
5.8.2 Cantel Medical Corporation Main Business
5.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Products, Services and Solutions
5.8.4 Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Cantel Medical Corporation Recent Developments
5.9 Nordion
5.9.1 Nordion Profile
5.9.2 Nordion Main Business
5.9.3 Nordion Hospital-Acquired Disease Testing Products, Services and Solutions
5.9.4 Nordion Hospital-Acquired Disease Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Nordion Recent Developments
6 North America
6.1 North America Hospital-Acquired Disease Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Hospital-Acquired Disease Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hospital-Acquired Disease Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hospital-Acquired Disease Testing Market Dynamics
11.1 Hospital-Acquired Disease Testing Industry Trends
11.2 Hospital-Acquired Disease Testing Market Drivers
11.3 Hospital-Acquired Disease Testing Market Challenges
11.4 Hospital-Acquired Disease Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
